Choi Sae Byeol, Park Joon Seong, Kim Jae Keun, Hyung Woo Jin, Kim Kyung Sik, Yoon Dong Sup, Lee Woo Jung, Kim Byong Ro
Department of Surgery, Yonsei University College of Medicine, 250 Seongsanno, Seodaemun-gu, Seoul 120-752, Korea.
Yonsei Med J. 2008 Aug 30;49(4):632-8. doi: 10.3349/ymj.2008.49.4.632.
The surgical robotic system is superior to traditional laparoscopy in regards to 3-dimensional images and better instrumentations. Robotic surgery for hepatic resection has not yet been extensively reported.
Between March and May 2007, we performed 3 robot-assisted left lateral sectionectomies of the liver. Case 1 had a hepatocellular carcinoma (HCC), case 2 had colon cancer with liver metastasis, and case 3 had intrahepatic duct stones.
All patients had successful operation and recovered without complications. Shorter length of hospital stays, earlier start of oral feeding and less amount of ascites were found. However, case 1 had recurrent HCC at 3 months after operation.
Robotic-assisted liver surgery is still a new field in its developing stage. In patients with small malignant tumors and benign liver diseases, robotic-assisted laparoscopic resection is feasible and safe. Through experience, the use of robotics is expected to increase in the treatment of benign diseases and malignant neoplasms. However, careful patient selection is important and long-term outcomes need to be evaluated.
手术机器人系统在三维图像和更好的器械方面优于传统腹腔镜检查。肝切除的机器人手术尚未得到广泛报道。
2007年3月至5月期间,我们进行了3例机器人辅助的肝左外侧叶切除术。病例1患有肝细胞癌(HCC),病例2患有结肠癌伴肝转移,病例3患有肝内胆管结石。
所有患者手术均成功,且康复过程中无并发症。发现住院时间较短、开始经口进食较早且腹水量较少。然而,病例1在术后3个月出现复发性HCC。
机器人辅助肝脏手术仍处于发展阶段的新领域。对于小的恶性肿瘤和良性肝脏疾病患者,机器人辅助腹腔镜切除术是可行且安全的。通过经验积累,机器人技术在良性疾病和恶性肿瘤治疗中的应用有望增加。然而,谨慎选择患者很重要,并且需要评估长期结果。